Clinical trial · Observational
Effect of Electrosurgery on Blood Loss and Intraoperative Transfusions in Musculoskeletal Tumor Surgery
Effect of Monopolar Tungsten Needle Electrodes and Teflon Coated Spatula Electrodes on Blood Loss and Intraoperative Transfusions in Musculoskeletal Tumor Surgery Compared to Conventional Surgical Knives and Stainless-Steel Electrodes
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Resection of malign musculoskeletal tumors and reconstruction with large tumor prostheses often results in relevant blood loss requiring hemodynamic stabilization and transfusion. The use of novel electrosurgical electrodes is assessed retrospectively regarding the potential to reduce blood loss and the need for transfusions.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Blood Loss, Surgical | — | UNRESOLVED | — |
| Electrosurgery | — | UNRESOLVED | — |
| Transfusion Rate | — | UNRESOLVED | — |
| Tumororthopaedics | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Application of novel electrodes | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Tungsten/Teflon +
- description
- Dissection with novel electrodes (Tungsten needle electrode + Teflon coated Spatula electrode)
- interventionNames
- Device: Application of novel electrodes
- label
- Tungsten/Teflon -
- description
- Dissection without novel electrodes (Scalpel + Steel Spatula Electrode)
Primary outcomes (3)
- measure
- Blood loss
- timeFrame
- during surgery
- description
- monitored during surgery in the anaesthesiology protocol
- measure
- Transfusion of red packed blood cells
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who received hemipelvectomy, hip disarticulation, or major tumor prosthesis implantation at our hospital between 2010 and 2021 * Operated by one single surgeon Exclusion Criteria: \- Implantation of a Megaprosthesis without history of tumor
References
Publications (1)
- DERIVEDPuetzler J, Steinbicker AU, Santel J, Deventer N, Jahn M, Zarbock A, Gosheger G, Schulze M, Jenke DJ. Blood-saving dissection with monopolar tungsten needle electrodes and Teflon-coated spatula electrodes in tumor orthopedics. J Orthop Traumatol. 2023 May 15;24(1):22. doi: 10.1186/s10195-023-00704-8. PMID 37188890